Month: March 2023

Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Updates

Written by Customer Service on March 27, 2023. Posted in Earnings Releases And Operating Results.

– Announces key appointments in oncology R&D and business development functions – Cash and cash equivalents of $283 million expected to provide runway into 2026 FOSTER CITY, Calif., March 27, 2023 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology, non-alcoholic steatohepatitis (NASH) and obesity today reported financial results for the fourth quarter and full year ended December 31, 2022 and corporate updates. “As announced in our release earlier this month, 2023 promises to be another transformative year for Terns as we make meaningful strides to advance our pipeline of medicines to address serious unmet needs. In addition...

Rigetti Computing Reports Fourth-Quarter and Full-Year 2022 Results

Written by Customer Service on March 27, 2023. Posted in Earnings Releases And Operating Results.

Strategic Focus on Achieving 99% 2-Qubit Median Fidelity on 84 Qubit Chip BERKELEY, Calif., March 27, 2023 (GLOBE NEWSWIRE) — Rigetti Computing, Inc. (Nasdaq: RGTI) (“Rigetti” or the “Company”), a pioneer in full-stack quantum-classical computing, today announced its financial results for the fourth quarter and year ended December 31, 2022. Fourth Quarter of 2022Total revenues for the three months ended December 31, 2022 were $6.1 million, compared to $1.8 million in the same period of 2021. Total operating expenses for the three months ended December 31, 2022 were $32.0 million, compared to $12.2 million in the same period of 2021. Operating loss for the three months ended December 31, 2022 was $26.7 million, compared to $11.1 million in the same period of 2021. Net loss for the three months ended December 31, 2022 was $22.9...

Harpoon Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update

Written by Customer Service on March 27, 2023. Posted in Earnings Releases And Operating Results.

HPN217 (BCMA) and HPN328 (DLL3) enrollment on track, with data updates and selection of recommended Phase 2 doses for both active clinical programs planned in 2023 Completion of $25 million preferred equity financing provides sufficient cash to fund operations into the second half of 2024, beyond key data milestones Five posters on multiple programs to be presented at AACR 2023 in April SOUTH SAN FRANCISCO, Calif., March 27, 2023 (GLOBE NEWSWIRE) — Harpoon Therapeutics, Inc. (Nasdaq: HARP), a clinical-stage immuno-oncology company developing novel T cell engagers, today reported financial results for the fourth quarter and full year ended December 31, 2022 and provided a corporate update. “Harpoon is well positioned to reach 2023 key milestones on our HPN217 and HPN328 clinical studies with a solid balance sheet extending the cash...

Acer Therapeutics Reports Q4 and Full Year 2022 Financial Results and Provides Corporate Update

Written by Customer Service on March 27, 2023. Posted in Earnings Releases And Operating Results.

NEWTON, Mass., March 27, 2023 (GLOBE NEWSWIRE) — Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious, rare and life-threatening diseases with significant unmet medical needs, today reported financial results for Q4 and full year ended December 31, 2022, and provided an update on the Company’s recent corporate developments. “2022 marked Acer’s first U.S. Food and Drug Administration (FDA) product approval, for OLPRUVA™ (sodium phenylbutyrate), an innovative and responsibly priced treatment option for certain people with urea cycle disorders (UCDs) involving deficiencies of carbamylphosphate synthetase (CPS), ornithine transcarbamylase (OTC), or argininosuccinic acid synthetase (AS),” commented Chris Schelling, CEO and Founder...

Disclosure of transactions in own shares from March 20th to March 24th, 2023

Written by Customer Service on March 27, 2023. Posted in Public Companies.

Nanterre, March 27th, 2023 Disclosure of transactions in own shares From March 20th to March 24th, 2023 Within the framework of the authorization granted by the General Meeting of VINCI SA of April 12, 2022 to trade in its shares and in accordance with the regulations relating to share buybacks, VINCI SA (LEI:213800WFQ334R8UXUG83) declares the purchases of treasury shares below (FR0000125486), carried out from March 20th to March 24th, 2023: I – Aggregate presentation by day and by marketIssuer’s name Date of transaction Identifying code of financial instrument Aggregated daily volume (in number of shares) Daily weighted average price of the purchased shares in Euro Market (MIC code)VINCI 20-Mar-23 FR0000125486 7 604 102,8995 XPARVINCI 20-Mar-23 FR0000125486 4 390 102,9191 CEUXVINCI 20-Mar-23 FR0000125486 1...

Nokia Corporation: Repurchase of own shares on 27.03.2023

Written by Customer Service on March 27, 2023. Posted in Public Companies.

Nokia CorporationStock Exchange Release27 March 2023 at 21:00 EEST Nokia Corporation: Repurchase of own shares on 27.03.2023 Espoo, Finland – On 27 March 2023 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows:Trading venue (MIC Code) Number of shares Weighted average price / share, EUR*XHEL 284,418 4.39CEUX 14,307 4.40AQEU 290 4.39TQEX 985 4.38Total 300,000 4.39* Rounded to two decimals On 3 February 2022, Nokia announced that its Board of Directors is initiating a share buyback program under the authorization granted by Nokia’s Annual General Meeting on 8 April 2021 to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The second phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014...

ONWARD Reports 2022 Full Year Financial and Operating Results

Written by Customer Service on March 27, 2023. Posted in Earnings Releases And Operating Results.

Company also Provides Business Update and Outlook for 2023 – Conference Call and Webcast (in English) March 28, 2023, at 2:00 PM CEST/8:00 AM EDT THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) EINDHOVEN, the Netherlands, LAUSANNE, Switzerland & BOSTON, MA USA, March 27, 2023 (GLOBE NEWSWIRE) — ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury, today announces its 2022 financial and operating results. The full Annual Report is available here, on the Company’s website in the Investors section (https://ir.onwd.com), and on the website of the Netherlands Authority for the Financial Markets (www.afm.nl). “I am...

Convocation of the 2023 Annual General Meeting of Shareholders and Proposed Resolutions

Written by Customer Service on March 27, 2023. Posted in Public Companies.

THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014). EINDHOVEN, Pays-Bas et LAUSANNE, Suisse, et BOSTON, MA, Etats-Unis, March 27, 2023 (GLOBE NEWSWIRE) — ONWARD Medical N.V. (Euronext: ONWD) (the Company), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury, today has convened the 2023 Annual General Meeting of Shareholders (AGM), including the resolutions to be submitted for adoption at the AGM, which will be held in Amsterdam, the Netherlands, on May 8, 2023. The resolutions, proposed by the Board, to be submitted for adoption at the AGM, are as follows:Adoption of the Company’s statutory annual accounts for the financial year ended December 31, 2022, prepared...

Aerojet Rocketdyne Selected by Lockheed Martin to Power Additional THAAD Interceptors

Written by Customer Service on March 27, 2023. Posted in Public Companies.

THAAD infographic Aerojet Rocketdyne’s reliable propulsion powers THAADHUNTSVILLE, Ala., March 27, 2023 (GLOBE NEWSWIRE) — Aerojet Rocketdyne has been awarded a new contract by Lockheed Martin to produce additional solid rocket motors and Divert and Attitude Control Systems (DACS) for the Terminal High Altitude Area Defense (THAAD) weapon system for the Missile Defense Agency. The contract includes interceptor propulsion for U.S. government lots 13/14 as well as Foreign Military Sales. THAAD is one of the nation’s primary defenses against short, medium and intermediate-range missiles. “For more than two decades, Aerojet Rocketdyne has powered THAAD, a missile defense system that protects our nation, our military service members and our allies,” said Eileen P. Drake, Aerojet Rocketdyne CEO and president. “Precision in everything...

OpenLocker Continues to Prove out it’s Winning Name Image and Likeness (NIL) Strategy with Two of it’s NIL Clubs reaching the Final Four and Holding an Historic one-of-a-Kind Experience with the University of Florida Gymnastics Team

Written by Customer Service on March 27, 2023. Posted in Public Companies.

West Palm Beach, FL, March 27, 2023 (GLOBE NEWSWIRE) — OpenLocker, Inc., a subsidiary of OpenLocker Holdings Inc. (“OpenLocker” or the “Company”) (OTCQB: OLKR), celebrates the advance of the Florida Atlantic University (FAU) Owls to the semifinals of the NCAA Men’s Basketball Tournament, which marks the team’s first appearance. In February, OpenLocker released a collection of digital and physical collectibles featuring the Name, Image and Likeness of all fourteen members of the FAU team which grant membership in the Prowlerz Club, an exclusive fan community that offers perks and real world rewards tied to athlete and team achievements. The University of Connecticut Huskies will be making their 37th appearance in the Final Four. The Bone Yard Huskyz Club was the Company’s first foray into NIL last season, the first since the NCAA...

Month: March 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals